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Hydrogen peroxide and beyond - the potential of high-voltage plasma-
activated liquids against cancerous cells 
Daniela Boehm, James Curtin, PJ Cullen and Paula Bourke* 
Plasma Research Group, School of Food Science and Environmental Health, Dublin 
Institute of Technology, Dublin 1, Ireland 
Abstract: The use of plasma-activated liquids such as PBS, medium or simply plasma-activated water (PAW) 
has been receiving increasing attention for applications in cancer treatments. Amongst the reactive species 
contained in these solutions, hydrogen peroxide appears to play a pivotal role in causing cytotoxic effects. 
While H2O2 concentrations can be correlated with reduced cell viability and growth and used as an indicator of 
the potential efficacy of a plasma-activated water, comparisons to standard H2O2 kill curves demonstrate a 
potency in PAW which exceeds H2O2 associated toxicity, indicating that other plasma-generated species play an 
important role.  
Using a high-voltage dielectric barrier atmospheric cold plasma (DBD-ACP) system, we demonstrate the generation of 
plasma-activated water with high cytotoxic potential and good storage stability. The potency of the activated solutions can 
be modulated using system or process characteristics such as voltage level, treatment time and post-treatment storage time 
and target-related characteristics such as surface to volume ratio. All of these parameters were found to impact cell 
viability in a hydrogen peroxide concentration correlated manner. The susceptibility of two cancer cell lines to PAW was 
similar to that observed for two non-cancer cell lines and the toxicity of plasma-activated water exceeded that of the 
corresponding hydrogen peroxide concentrations. 
This study examines the role of H2O2 in PAW-mediated cytotoxic effects on different mammalian cells lines and 
investigates effects beyond H2O2 employing a set-up where short-lived reactive species can be discounted and activated 
liquids with long-term stability are generated. Here we investigate the cytotoxic mediators generated in water specific to 
high-voltage DBD-ACP. 
Keywords: plasma activated water, ROS, RNS, cytotoxicity, hydrogen peroxide, peroxynitrite, peroxynitrate. 
1. INTRODUCTION 
 Solutions exposed to plasma discharges provide a novel 
resource which can be tailored to a range of applications in 
medicine and healthcare. Cytostatic or cytotoxic effects of 
plasma activated liquids in mammalian systems have 
sparked interest in their investigation as novel cancer 
therapeutics and efficacy has been demonstrated in a number 
of different cancer cells including glioblastoma, ovarian, 
bladder cancer and lung cancer [1-5]. However, a holistic 
insight into the mechanisms governing these liquid-mediated 
effects of plasma exposure and the main chemical effector 
species is required to release the full potential of this 
technology, to develop possible applications and to inform 
safety considerations depending on the cell type and 
application in question. 
Investigations of non-thermal plasma in cancer treatment to 
date have largely been performed by exposing cells directly 
to plasma discharge or plasma afterglow, where a range of 
plasma devices have been utilized on various cancerous cells 
[6, 7]. The ionization of gas in a plasma discharge produces 
a range of reactive oxygen and reactive nitrogen species 
(ROS/RNS) such as ozone, atomic oxygen, superoxide  
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anion, hydroxyl radical, hydrogen peroxide and nitric oxides 
[8]. These reactive species can react with proteins, lipids and 
nucleic acids and cause damage to the cellular envelope and 
intracellular components including enzymes and DNA. 
Increased intracellular levels of ROS and RNS can lead to 
mitochondrial disfunction, cell cycle arrest, altered cell 
signaling and apoptosis [6, 7] and both extra and intracellular 
ROS scavengers have been shown to protect cells from 
cytotoxic/anti-proliferative effects [9]. In situ generation of 
OH radicals through the Fenton reaction may be one of the 
main causes of plasma-induced cell death derived from O2- 
and H2O2 in plasma effluents and plasma treated liquids [10, 
11]. Yet ROS-independent mechanisms of cell death in 
response to non-thermal plasma have also been described 
[12]. 
 
Many of the effects of plasma treatment (the major 
exceptions being electric field and UV radiation) are 
mediated through reactive species in liquid at the cell – 
plasma interface, thus many of the effective observed 
phenomena and pathways are likely to be implicated in the 
action of plasma activated liquids. 
The exposure of aqueous solutions to atmospheric plasmas 
results in the generation of secondary products such as 
hydrogen peroxide, nitrates and nitrites which may react to 
form further cell toxic compounds such as peroxynitrite/ 
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peroxynitrous acid. A dominant function for H2O2 in the 
cytotoxic effects of plasma-activated liquids has been 
established through a number of studies [1, 13-18] but, 
importantly it has also been shown that this compound is not 
the sole toxic mediator. Hydrogen peroxide can induce DNA 
damage, cause cell cycle arrest and trigger apoptosis and its 
toxicity is determined largely by the cellular anti-oxidant 
status and ability to detoxify H2O2 through catalase.  
The cytotoxic effects of plasma activated medium (PAM) 
have been suggested to be selective for cancer cells in some 
studies including glioblastoma cells and ovarian cancer cells, 
and exposure to PAM inhibited the growth of tumour 
spheroids in vitro while PAM injection into subcutaneous 
tumours in mice resulted in a reduction of tumour size in 
vivo [18-20].  
This purported selectivity for cancerous cells has been 
proposed to result from increased baseline endogenous ROS 
levels in these cells resulting from aberrant metabolism [9] 
or an increased surface expression of aquaporins which 
results in greater uptake of reactive species such as H2O2 [5, 
21] but definite selectivity remains to be shown [22]. More 
recently, it has been argued that the main potential of plasma 
in cancer therapy may lie in propagation of the effects 
through bystander effects on the surrounding tissue and the 
activation of the immune system through immunogenic cell 
death (ICD) [23]. 
Much work has been performed on the identification of 
reactive species in plasma activated liquids and their 
resulting cytotoxic effects. It is increasingly evident that very 
different chemistries can prevail depending on the type of 
plasma system used, the gas in which discharge occurs as 
well as a range of device-based parameters and target 
characteristics [24]. Water becomes acidified during plasma 
treatment and H2O2, nitrites and nitrates are reactive species 
most commonly detected. However, their concentrations can 
vary strongly from undetectable to mM ranges depending on 
device configuration or working gas. In plasma activated 
water generated using indirect DBD discharge, Traylor and 
colleagues reported detection of H2O2 around 100µM and 
nitrites and nitrates of 1-5mM [25]. The composition of 
PAW generated with a glidarc depended on the configuration 
of the gliding arc reactor used and the working gas, where 
H2O2, nitrites and nitrates were obtained in varying 
concentrations from undetectable to mM [26]. 
Using an RF plasma-jet, Wende and co-workers showed 
H2O2 dominated cytotoxicity when using argon and 
humidified argon as feed gas but suggest atomic oxygen to 
mediate toxicity in argon/air and argon/oxygen mixtures 
where H2O2 is only found in trace amounts [27]. The choice 
of target liquid furthermore modulates reactive species 
production through buffering capacities (e.g. PBS), 
scavenging potential (antioxidants in cell culture medium) or 
selective formation of secondary reactive species. Atomic 
oxygen for example has been proposed to react with chloride 
ions in saline to form cytotoxic ClO- or Cl2- [27]. In a recent 
study, Girard and colleagues demonstrated the synergistic 
effect of H2O2 and nitrite in killing normal as well as 
cancerous cells and conclude a similar mechanism of action 
for the effects of a He plasma jet [16]. The cytotoxic effects 
of plasma-activated medium depend on the amino acids 
present, on scavengers such as pyruvate and can be 
modulated through the addition of FBS [1, 28-30]. 
Therefore, a generalization on the identity of cell-toxic 
effectors in plasma-activated liquids becomes difficult. In 
this study we focus on the properties and cytotoxic mediators 
of plasma activated water generated using a high-voltage di-
electric barrier discharge system where plasma discharge is 
generated in air. A contained post-treatment storage time 
(PTST) significantly increases the efficacy of the PAW and 
suggests the longer-lasting species as key effectors.  
2. MATERIALS AND METHODS  
2.1. Plasma system 
 Plasma treatment was performed using a high-voltage di-
electric barrier discharge atmospheric cold plasma system 
custom built at Dublin Institute of Technology (Dublin, 
Ireland) with a maximum output of 120 kVRMS at 50 Hz 
which has been described in detail [31, 32]. 
2.2. Plasma treatment 
 Deionized water was placed in the discharge area in 
multi-well plates or petri-dishes inside a polypropylene 
container and sealed with air-tight film. The samples were 
placed either directly in the area of discharge between high 
voltage and ground electrode (in-field, IF) or within the 
sealed box but outside of the area of discharge (out-field, 
OF). Plasma was generated at 80 kVRMS in air, solutions 
were subjected to 24 hour post treatment storage time at 
room temperature before opening unless otherwise specified. 
Plasma activated water was subsequently stored at 4°C. 
2.3. Chemical analyses 
 Unless specified otherwise all reagents were purchased 
from Sigma-Aldrich, Arklow, Ireland. Hydrogen peroxide 
concentrations in solution were determined using oxidation 
of potassium iodide to iodine and spectrophotometric 
measurement at 390 nm or reaction with sulfuric acid 
solution of TiOSO4, measured at 405nm. A standard curve of 
known hydrogen peroxide concentrations was included on 
each plate and used to convert absorbances into peroxide 
concentrations. pH measurements were performed using a 
Orion pH meter model 420A (Thermo Fisher Scientific). 
Nitrite concentrations were determined using Griess reagent 
and spectrophotometric measurement at 548nm after 30min 
incubation and compared to a sodium nitrite standard curve. 
Nitrate concentrations were assessed using a nitrate 
spectrophotometric assay kit (Merck Chemicals, Darmstadt, 
Germany). 
UV absorption spectra were obtained with a Shimadzu UV-
1800 UV/Vis spectrophotometer (Shimadzu, Kyoto, Japan).  
2.4. Cell culture 
 Cell lines were obtained from culture stocks of Dublin 
Institute of Technology or University College Dublin. The 
following established human cancerous cell lines were used: 
human cervical carcinoma HeLa and human glioblastoma 
U373MG; and the human immortalized human keratinocyte 
HaCaT. Chinese hamster ovary (CHO-K1) cells were 
included as a further non cancer line for which the DBD 
plasma device has previously been characterized with regard 
to cytotoxic and genotoxic effects. Cells were cultured in 
DMEM/F12 medium supplemented with 2 mM L-glutamine 
and 10% foetal bovine serum (FBS). Cells were grown at 
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37°C and 5% CO2 in a humidified incubator. Cell 
concentrations and viability were assessed using trypan blue 
counting.  
 
 
2.5. Cytotoxicity assays 
 Cells were seeded at 2.5x104 cells/ml in DMEM/F12 + 
10% FBS supplemented with 20% of plasma activated water 
or respective H2O2 dilutions. Cell growth was assessed 
through quantification of cell mass by staining of adherent 
cells with crystal violet after 3-4 days in culture. Culture 
supernatant was removed and cells were fixed with 70% 
methanol for 1 min followed by staining with 0.2% crystal 
violet solution for 10 min. After extensive washes with 
water, plates were air-dried and the crystal violet was 
solubilized with 10% acetic acid and absorbance measured at 
560 nm on a spectrophotometric microplate reader (Biotek, 
Winooski, USA). Cell growth was expressed as percentage 
of control cells grown in medium supplemented with 
untreated water. 
2.6. Statistical analysis 
 Results represent the means of triplicate determinations. 
Standard deviations and statistical analysis where applicable 
were performed by analysis of variance (ANOVA) using 
GraphPad Prism (GraphPad Software Inc., La Jolla, USA). 
3. RESULTS AND DISCUSSIONS 
3.1. Plasma activated water 
 Plasma activated water was generated inside a sealed 
container either through direct plasma exposure by placing 
water samples in-field of the area of discharge or indirect 
treatment where samples were exposed to plasma-reactive 
species in the treated air but were outside of the actual area 
of discharging (out-field). 
Plasma-activated water generated using a high-voltage DBD 
system contained high concentrations of hydrogen peroxide 
but no detectable amounts of nitrite. The pH decreased to 2-3 
and remained stable. The concentrations of H2O2 produced 
could be modulated through the applied voltage, treatment 
time and also post-treatment storage time (PTST) specific to 
the contained plasma treatment set-up employed here (Fig. 
1) and remained stable over storage for several weeks at 4°C 
[13]. The stability of H2O2 concentrations in plasma-
activated solutions over time has been shown to depend on 
the absence of scavenging factors such as pyruvate or certain 
amino acids such methionine and cysteine [1, 33]. 
Introduction of post-treatment storage periods allows longer 
contact times for gas reactive species to react with and 
diffuse into the liquid phase. As demonstrated previously for 
this system high gas phase levels of ozone disappear within 
the 24h PTST [34].  
H2O2 concentrations were dependent on the surface area to 
volume ratio of the treated sample and increased with higher 
surface areas available for interaction with the gas phase for 
both in-field and out-field (Fig. 2). Similarly, higher 
concentrations of H2O2 were detected with increasing well 
diameter for plasma-activated medium, which translated to 
stronger cytotoxic effects in studies by Yan et al [30]. 
3.2. Cytotoxic effects 
Hydrogen peroxide has known cytotoxicity on mammalian 
cells but IC50 values diverge greatly between different cell 
lines, depending on cellular redox status and the cell’s ability 
to detoxify H2O2 through catalase. For the cell lines tested 
here, a greater than 3-fold difference was found between the 
most susceptible (HaCaT) and the most resistant (U373mg) 
(Fig. 3 and Table I). 
Cell growth in response to supplementation with plasma 
activated water (20% v/v) correlated with the solutions 
hydrogen peroxide concentrations in a dose dependent-
manner showing a characteristic response-inhibition curve 
(Fig. 4). However as reported previously the corresponding 
IC50s were in most cases strikingly lower than those 
obtained through H2O2 supplementation of the medium 
(Table 1). Moreover, the highly H2O2-resistant glioblastoma 
cell line U373mg (IC50 > 300 µM) showed an IC50 in PAW 
which was comparable to the other cell lines. In agreement 
with numerous studies, these observations confirm that 
mammalian cytotoxicity correlates with hydrogen peroxide 
content in plasma activated solutions but that this does not, 
however, constitute the only cytotoxic factor [13, 16].  
3.3. The role of pH 
 Non-buffered solutions become acidified during plasma 
treatment and this reduced pH has been shown to be crucial 
for cell toxic effects of plasma activated solutions on 
bacterial cells [35]. The addition of PAW to DMEM/F12 
medium, which is buffered both with HEPES and 
bicarbonate and contains 10% FBS, does not result in an 
acidification of the overall solution. The medium is able to 
buffer the addition of PAW up to concentrations of a total of 
80% (v/v) and significant changes in pH of the medium do 
not occur until an addition of HCl up to a total concentration 
of 10mM (Fig. 5a,b). In comparison, PAW is added only up 
to a total volume of 20% (v/v) or an equivalent of 0.1-1mM 
of H+ for a pH of 2-3. Any pH related effects of PAW when 
diluted in DMEM can hence be discounted.  
To exclude the possibility that acidic species in PAW are 
required for reactions with medium components to form 
other toxic -albeit pH neutral- reaction products- PAW was 
pH neutralized through the addition of concentrated PBS 
before addition to cell culture medium. The effects on cell 
growth did not differ between cultures supplemented with 
pH buffered PAW or PAW diluted respectively with H2O 
and comparable cytotoxic effects were elicited by both (Fig. 
6).  
3.4. The role of nitrites and nitrates 
Nitrites were not generated in detectable concentrations in 
contrast to many plasma activated liquids generated using 
jet-based systems. Supplementation of cell cultures with 
nitrite at concentrations up to 1200µM did not show 
cytotoxic effects on the cell lines tested and nitrite per se can 
thus be excluded as playing a role in the inhibition of cell 
growth (Fig. 7) in agreement with observations made by 
others [27]. Nitrate was generated in plasma-activated water 
in a treatment time dependent manner, reaching up to 
600µM. However, no cytotoxic effects of nitrate were found 
in this range or for 10-fold higher concentrations in the 
mammalian cells tested (Fig. 7b).  
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Hydrogen peroxide reacts with nitrite to reaction products 
such as nitrate (NO3-) and peroxynitrite (ONOO-). As shown 
in Fig. 8, titration of H2O2 with sodium nitrite results in a 
loss of H2O2 signal as detected using TiOSO4 (Fig. 8b), but 
insubstantial changes only in the oxidative signal detected 
using KI (Fig. 8a). Peroxynitrous acid can be generated 
through reaction of H2O2 and nitrite at acidic pH and may be 
the oxidative species which reacts with the potassium iodide. 
Sodium nitrate of concentrations from 60µM to 6000µM 
showed no reaction with potassium iodide. 
Peroxynitrite/peroxynitrous acid is a secondary reactive 
species produced in plasma exposed liquids and - as a known 
cell toxic agent - has been discussed to be responsible for 
biocidal effects in both microbial and mammalian cell 
systems [25, 36-38]. The generation of peroxynitrite has 
been indicated in various experimental set-ups but its 
detection is complicated by its inherent instability and a lack 
of specific assays due to cross-reactivity of other ROS/RNS. 
The transient formation of peroxynitrite has been 
demonstrated in PBS at alkaline pH treated with He/1%N2 
plasma [39]. At neutral pH and 37°C this species has a half-
life of 1 sec [40] and would decompose instantaneously upon 
dilution in cell culture medium. On the other hand, with 
direct plasma treatment of cells or tissues, the generation of 
peroxynitrite and subsequent reactions with bio-molecules 
may play an important role in plasma-induced cell damage. 
Reactions with components of the cell culture medium are 
possible and could result in oxidation or nitration of protein 
residues. 
Cells supplemented with nitrite at concentrations from 6µM 
to 100µM and 65µM H2O2 responded to the toxic effects of 
hydrogen peroxide but indicated no increased toxicity of 
nitrite and H2O2 combined (Fig. 9). These findings are in 
agreement with observations by Wende and co-workers who 
tested 125µM nitrite against a range of H2O2 concentrations 
and found no impact on the IC50 [27]. A synergy of H2O2 
and nitrite in cytotoxic effects on both normal and malignant 
cells was, however, reported by Girard and colleagues who 
suggested this synergy as a basis for the cytotoxicity of 
plasma treatment with a Helium jet [16]. 
UV spectra of plasma activated water displayed an 
absorption peak between 200 and 220nm which increased 
with treatment time. While this lies in the absorption region 
of both nitrite and nitrate (Fig. 10, 11), no nitrite was 
detectable by chemical analysis. Nitrate was detected in 
concentrations ranging up to 600µM and can be assumed as 
a main contributor to the observed spectrum. 
The formation of peroxynitric acid as a decomposition 
product of peroxynitrite at neutral pH has been stipulated 
[41]. Kitano and co-workers, who successfully isolated and 
characterized peroxynitric acid using low temperature, low 
pH ion exchange chromatography [42], recently proposed it 
as the major biocidal reactive species in plasma treated water 
at the International Conference for Plasma Medicine 6 
(ICPM6). Peroxynitric acid/peroxynitrate (PNA) and 
peroxynitrous acid/peroxynitrite (PNI) possess similar 2 
electron oxidative behavior but differ in their stability as a 
function of pH and CO2 [43]. While the formation of 
peroxynitrate from decomposition of peroxynitrite at neutral 
pH to alkaline pH has been shown, it can also be formed 
through the reaction of O2- with NO2 [44], and these are 
reactive species which can be generated in plasma discharge 
in air. The analysis of the gas phase during discharge of the 
DBD system used here has shown the generation of NO2 
while high concentrations of ozone were measured after 
treatment but decreased to undetectable levels within 24 
hours [31, 34]. The superoxide anion radical is one of the 
products in the chain reaction of ozone decomposition in 
water and could react with the NO2 in a sealed environment. 
Generation of peroxynitric acid in solution requires extreme 
reaction conditions such as > 90% H2O2 and 70% HNO3 or 
pulse radiolysis of oxygen saturated NaNO2 or NaNO3 
making it a difficult species to study [45]. Gupta and co-
workers have described the formation of peroxynitric acid 
with an absorption maximum at 284nm [41]. 
Examination of UV spectra obtained of plasma activated 
water used here, indicates an absorption peak around 280nm 
in some samples (Fig. 11b), a peak observed for neither 
NaNO2 nor NaNO3 (Fig. 10b). Whilst further detailed 
chemical analysis is required, the possible generation of 
peroxynitric acid/peroxynitrate through high voltage 
treatment of water is proposed as a source of reactive species 
with cytotoxic activity in addition to H2O2 in the plasma 
activated water used here. 
CONCLUSION 
 Despite the intensification of research on the effects of 
plasma-activated liquids on mammalian cells and cancerous 
cells in particular towards potential applications in cancer 
therapy, the exact cause-effect relationships of ‘plasma-
liquid-cell’ remain incompletely elucidated.  
A myriad of reactive species and biologically relevant 
factors are generated in plasma discharges. These differ in 
response with the plasma device employed and its operating 
parameters. It is therefore not surprising that a range of 
different reactive species have been identified in plasma-
treated liquids where the choice of liquid adds a further 
degree of variability. Importantly, it may be within this 
diversity that the distinct potential of plasma-activated 
liquids for inducing cell death of cancerous cells lies. 
Eukaryotic cells possess an arsenal of mechanisms to deal 
with potentially fatal stress resulting from ROS and RNS. 
These include anti-oxidants such as glutathione, thioredoxin 
and highly specialized enzymes such as catalase and super 
oxide dismutase. Providing challenges on multiple fronts 
may overcome these cellular defenses and result in an 
accumulation of damage that ultimately halts cell cycle 
progression and leads to apoptotic cell death. Providing a 
challenge that activates multiple cell defences may also be 
less prone to the development of resistances. 
In cytotoxic plasma activated water an essential role for 
H2O2 has been demonstrated multi-fold, yet further 
contributing factors are apparent and remain to be identified. 
In this study, the post-treatment storage time at room 
temperature for 24 hours not only enhanced the cytotoxic 
potency of the PAW but this also rules out short-lived factors as 
causative agents. We hypothesize that a cytotoxic agent 
produced using the DBD set-up described here, which acts 
additively/synergistically with H2O2, could be peroxynitic 
acid/peroxynitrate.  
It remains to be established with certainty that PAW selectively 
inhibits cancerous cells by comparison with normal cells. 
However, an unspecific cytotoxic effect on dividing cells may 
Short Running Title of the Article Journal Name, 2014, Vol. 0, No. 0    5 
well suffice to make this product relevant to further cancer-
therapeutic research, where certain tumour cells could be 
targeted through localized application and retention. Using a 
well characterized high-voltage system with species 
containment we generate a cell-toxic liquid using the simplest of 
media available, i.e. water. The contained approach, previously 
applied for decontamination of packaged foods or medical 
products[46, 47], holds further promise not only for its ability to 
increase levels of stable cytotoxic effectors but could also 
generate a sterile product protected against contamination prior 
to its potential application.  
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FIGURE LEGENDS 
 
Fig. 1: Generation of hydrogen peroxide in water exposed to DBD discharge at 80kV, in-field, dependent on treatment time and 
post-treatment storage time (PTST). Post-treatment storage time was assessed for samples treated at 80kV for 10 min (dashed 
line). 
 
Fig. 2: Hydrogen peroxide concentrations in plasma activated water depending on the volume to surface area ratios. 
 
Fig. 3: Dose-response curves of cell lines U373mg, HeLa, HaCaT and CHO-K1 to hydrogen peroxide. 
 
Fig. 4: Dose-response curves of cell lines U373mg, HeLa, HaCaT and CHO-K1 to supplementation with plasma activated 
water at 20% (v/v). H2O2 in plasma activated water was determined using TiOSO4 and KI method and cell growth is shown as 
function of final concentration of H2O2 after dilution in DMEM/F12 medium relative to cultures supplemented with pure water. 
 
Fig. 5a,b: Buffering capacity of DMEM/F12 medium for addition of acidic plasma activated water (a) and 10mM HCl (b). 
Circle and square indicate the corresponding concentration range of plasma activated water supplementation used in cell culture 
experiments. 
 
Fig. 6: Cell growth of HaCaT cells in response to supplementation with plasma activated water, pH-neutralized by addition of 
4.5x PBS or control-diluted with water. Cells were supplemented with a total of 20% (v/v) plasma activated water and cell 
growth is shown as function of the respective final hydrogen peroxide concentrations. 
 
Fig. 7a, b: Cell growth in response to supplementation with NaNO2 (a) and NaNO3 (b). Sodium Nitrite or nitrate solutions of 
60-6000µM were added into the cell culture medium at 20% (v/v) resulting in final concentrations between 12 and 1200 µM. 
 
Fig. 8a,b: Reaction of sodium nitrite with hydrogen peroxide shows no change in oxidation of potassium iodide (a) but loses its 
capability to react with TiOSO4 when concentrations of nitrite are in excess (b). A matrix of NaNO2 and H2O2 concentrations 
was set up ranging from 0-6000µM of each compound and each concentration of NaNO2 was mixed 1:1 with each 
concentration of H2O2. 
 
Fig. 9: Cell growth in response to supplementation with NaNO2/H2O2 mixtures. Cells were supplemented at 20% (v/v) with 
NaNO2 (closed symbols) or NaNO2 and H2O2 (open symbols). NaNO2 was used at a final concentration of 6-100µM, H2O2 at 
65µM. Cell growth is shown relative to control cultures with 20% v/v water. 
 
Fig. 10: UV spectra of sodium nitrite (600µM, 300µM), sodium nitrate (600µM, 300µM), hydrogen peroxide (600µM) and 
mixtures thereof. Spectra for 300µM NaNO2 (dotted line) and a mixture of 600µM H2O2 and 600µM NaNO2 (long dash) 
overlapped almost identically. Overview spectra shown from 190-400nm (a) and detailed spectra from 250-400nm (b). 
 
Fig. 11: UV spectra of plasma activated water generated at different treatment and post-treatment storage times with in-field 
(IF) or out-field (OF) treatment. Overview spectra shown from 190-400nm (a) and detailed spectra from 250-400nm (b). 
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Figure 5a,b 
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Figure 8a,b 
 
Figure 9 
0 50 100
0
50
100
150
U373mg
U373mg + H2O2
HeLa
HeLa + H2O2
conc NaNO2 [M]
c
e
ll
 g
ro
w
th
 [
%
 c
o
n
tr
o
l]
Short Running Title of the Article Journal Name, 2014, Vol. 0, No. 0    13 
a 
b 
 
Figure 10a,b 
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TABLES 
Table I: IC50 values (from curve fit) of cultures supplemented with pure hydrogen peroxide or PAW. 
 IC50 H2O2 (pure) 
[µM] 
IC50 H2O2 (PAW) 
[µM] 
CHO-K1 225 105 
HeLa 105 140 
HaCaT 95 80 
U373mg 315 185 
 
 
